Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other brokerages also recently weighed in on NHI. ValuEngine raised shares of National Health Investors from a hold rating to a buy rating in a research note on Tuesday, December 11th. BMO Capital Markets downgraded shares of National Health Investors from a market perform rating to an underperform rating and set a $78.00 target price for the company. in a research note on Wednesday, February 20th. KeyCorp set a $65.00 price target on shares of National Health Investors and gave the stock a sell rating in a research report on Thursday, December 20th. Finally, SunTrust Banks lifted their price target on shares of National Health Investors to $85.00 and gave the stock a neutral rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. National Health Investors presently has a consensus rating of Hold and an average price target of $78.14.
National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.52). National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. The company had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. During the same period in the prior year, the firm posted $1.35 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis. On average, equities research analysts anticipate that National Health Investors will post 5.5 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, March 29th will be given a dividend of $1.05 per share. This is a boost from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date is Thursday, March 28th. This represents a $4.20 annualized dividend and a dividend yield of 5.30%. National Health Investors’s payout ratio is currently 72.99%.
In other news, Director Robert A. Mccabe, Jr. sold 1,181 shares of National Health Investors stock in a transaction that occurred on Thursday, February 21st. The shares were sold at an average price of $78.04, for a total transaction of $92,165.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 5.63% of the stock is owned by insiders.
Large investors have recently modified their holdings of the company. Russell Investments Group Ltd. grew its holdings in National Health Investors by 16.3% during the third quarter. Russell Investments Group Ltd. now owns 33,606 shares of the real estate investment trust’s stock valued at $2,540,000 after purchasing an additional 4,710 shares during the period. Wells Fargo & Company MN grew its holdings in National Health Investors by 1.8% during the third quarter. Wells Fargo & Company MN now owns 152,385 shares of the real estate investment trust’s stock valued at $11,519,000 after purchasing an additional 2,721 shares during the period. Meeder Asset Management Inc. grew its holdings in National Health Investors by 1,298.1% during the third quarter. Meeder Asset Management Inc. now owns 3,020 shares of the real estate investment trust’s stock valued at $228,000 after purchasing an additional 2,804 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in National Health Investors by 23.3% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,390 shares of the real estate investment trust’s stock valued at $559,000 after purchasing an additional 1,395 shares during the period. Finally, American Century Companies Inc. acquired a new position in National Health Investors during the third quarter valued at approximately $5,651,000. Institutional investors own 70.77% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.